{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:26:05Z","timestamp":1764174365841},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijrobp.2017.01.242","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T17:30:58Z","timestamp":1486488658000},"page":"123-130","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Phase 1\/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly\u00a0Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results"],"prefix":"10.1016","volume":"98","author":[{"given":"Erqi L.","family":"Pollom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylann","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kira","family":"Seiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie A.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"von Eyben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Tupper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris C.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griffith R.","family":"Harsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciara","family":"Harraher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Nagpal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence D.","family":"Recht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Y.H.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott G.","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.01.242_bib1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1586\/14737167.5.6.763","article-title":"Health-related quality of life and symptom research in glioblastoma multiforme patients","volume":"5","author":"Taphoorn","year":"2005","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdl494","article-title":"Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making","volume":"18","author":"Efficace","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pec.2012.11.002","article-title":"Palliative and supportive care needs of patients with high-grade glioma and their carers: A systematic review of qualitative literature","volume":"91","author":"Moore","year":"2013","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1516-0","article-title":"Living longer with adult high-grade glioma: Setting a research agenda for patients and their caregivers","volume":"120","author":"Russell","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S1470-2045(05)70432-0","article-title":"Health-related quality of life in patients with glioblastoma: A randomised controlled trial","volume":"6","author":"Taphoorn","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijrobp.2013.02.013","article-title":"Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide","volume":"86","author":"Minniti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib8","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1158\/1078-0432.CCR-14-0822","article-title":"Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma","volume":"20","author":"Omuro","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11060-008-9689-z","article-title":"Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma","volume":"91","author":"Minniti","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib10","doi-asserted-by":"crossref","unstructured":"Azoulay M, Ho CK, Fujimoto DK, et al: A Phase I\/II Trial of 5 Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma Multiforme. Presented at American Society for Radiation Oncology, Annual Meeting 2016, Boston, MA.","DOI":"10.1016\/j.ijrobp.2016.06.921"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00435979","article-title":"The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires","volume":"5","author":"Osoba","year":"1996","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib13","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ejca.2010.01.012","article-title":"An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients","volume":"46","author":"Taphoorn","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib14","series-title":"Scoring Manual","article-title":"63 EORTC QLQ-C30","author":"Fayers","year":"2001"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpainsymman.2008.02.011","article-title":"Clinical utility of the MDASI-BT in patients with brain metastases","volume":"37","author":"Armstrong","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11060-006-9135-z","article-title":"Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT)","volume":"80","author":"Armstrong","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib18","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1200\/JCO.2013.49.6067","article-title":"Net clinical benefit analysis of radiation therapy oncology group 0525: A phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib19","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1200\/JCO.2014.60.3217","article-title":"Health-related quality of life in a randomized phase iii study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma","volume":"33","author":"Taphoorn","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib20","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0959-8049(00)00165-9","article-title":"Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide","volume":"36","author":"Osoba","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3102\/10769986025001060","article-title":"On the adaptive control of the false discovery rate in multiple testing with independent statistics","volume":"5","author":"Benjamini","year":"2000","journal-title":"J Educ Behav Stat"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/028418600750013384","article-title":"Health-related quality of life measured by the EORTC QLQ-C30: Reference values from a large sample of Swedish population","volume":"39","author":"Michelson","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0167-8140(94)90064-7","article-title":"Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma","volume":"33","author":"Thomas","year":"1994","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0360-3016(03)01623-7","article-title":"Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme","volume":"58","author":"Floyd","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-8140(99)00183-8","article-title":"Hypofractionation in glioblastoma multiforme","volume":"54","author":"Hulshof","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0360-3016(97)00222-8","article-title":"Short course radiotherapy is an appropriate option for most malignant glioma patients","volume":"38","author":"Kleinberg","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(03)00819-8","article-title":"The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: Preliminary results of a prospective trial","volume":"58","author":"Sultanem","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0360-3016(02)04522-4","article-title":"Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: Outcome and prognostic factors","volume":"56","author":"Chang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11060-006-9231-0","article-title":"Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma","volume":"81","author":"Ernst-Stecken","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-013-1159-6","article-title":"Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide","volume":"114","author":"Reddy","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijrobp.2008.10.043","article-title":"Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas","volume":"75","author":"Gutin","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1044\/1058-0360(2011\/10-0084)","article-title":"A qualitative study of interference with communicative participation across communication disorders in adults","volume":"20","author":"Baylor","year":"2011","journal-title":"Am J Speech Lang Pathol"},{"key":"10.1016\/j.ijrobp.2017.01.242_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/00206099309071867","article-title":"The impact of acquired hearing impairment on intimate relationships: Implications for rehabilitation","volume":"32","author":"Hetu","year":"1993","journal-title":"Audiology"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161730305X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161730305X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T10:18:16Z","timestamp":1719051496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161730305X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S036030161730305X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.01.242","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1\/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly\u00a0Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.01.242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}